COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias
Author:
Publisher
Elsevier BV
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference12 articles.
1. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China;Chang;JAMA,2020
2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China;Wang;JAMA,2020
3. Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19);Giudicessi;Mayo Clin Proc,2020
4. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes;Wu;Heart Rhythm,2020
5. Roden DM, Harrington RA, Poppas A, et al. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment. Published online April 14, 2020. Heart Rhythm https://doi.org/10.1016/j.hrthm.2020.04.016.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pathfinder-Driven Chemical Space Exploration and Multiparameter Optimization in Tandem with Glide/IFD and QSAR-Based Active Learning Approach to Prioritize Design Ideas for FEP+ Calculations of SARS-CoV-2 PLpro Inhibitors;Molecules;2022-12-05
2. Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir;European Journal of Therapeutics;2022-01-04
3. Antiviral and anti-inflammatory drugs to combat COVID-19: Effects on cardiac ion channels and risk of ventricular arrhythmias;BIOIMPACTS;2022
4. A case of paroxysmal complete atrioventricular block in a COVID‐19 patient;Clinical Case Reports;2021-10
5. Current evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir;Medicine;2021-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3